Lumida
/WALD
⌘K
Waldencast PLC

Waldencast PLC

WALD
$1.31USD↓-1.50%-0.02 today

MARKET CAP

168.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$1 – $1

52W RANGE

$1
$3

AI Summary

Stalk
Buy NowMedium

WALD is in a Stage 2 advancing regime with higher highs and higher lows above rising EMAs and the 50SMA, underpinning a bullish medium-term bias. The recent pullback into the 9/21 EMA is healthy and offers a constructive entry with neutral OB/OS context and no exhaustion. However, the longer-term trend remains down, and stage transition risk into distribution at the May highs underscores the need for caution. We will engage on this pullback into EMAs support.

  • ↑Obagi Medical divestiture raises up to $460M, enabling debt paydown and reinvestment in Milk Makeup
  • ↑Consensus price target hikes to $2.28 reflect undervalued Milk Makeup upside
  • ↓Negative earnings yield and low profitability factor highlight ongoing margin and return issues
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Waldencast PLC (NASDAQ: WALD) is an emerging player in the beauty and wellness space, specifically focusing on innovative skincare and cosmetics. The company has positioned itself within the growing segment of clean beauty, capitalizing on the trends towards natural and sustainable products. With its remaining brand, Milk Makeup, Waldencast aims to accelerate global growth and develop a reputation in the cosmetics market after the sale of its Obagi Medical dermatological business.

Bull says

  • ↑Obagi Medical divestiture raises up to $460M, enabling debt paydown and reinvestment in Milk Makeup
  • ↑Consensus price target hikes to $2.28 reflect undervalued Milk Makeup upside
  • ↑21.8% three-month forecast to $1.53–$2.54 signals renewed investor confidence
  • ↑High growth factor and upcoming Saypha injectables launch underpin potential revenue gains
  • ↑Manageable leverage and positive momentum factors suggest room for operational recovery

Bear says

  • ↓Negative earnings yield and low profitability factor highlight ongoing margin and return issues
  • ↓Very low size and liquidity factors raise doubts about WALD’s financial resilience
  • ↓13F ownership score indicates minimal institutional backing and muted stock demand
  • ↓Projected impairment charges and cash flow shortfalls may strain the balance sheet
  • ↓Lingering market skepticism and elevated short interest could cap near-term upside

Earnings Call · Q1 2024 · Mgmt. Guidance

Updated 05-15-2025bullish

Transcript signals

Bull points

  • our strong first quarter of 2024 results and resume our historical practice of holding earnings calls each quarter
  • Prestige Beauty closed 2023 at plus 14%, more than double Mass Beauty, momentum that continued albeit with a moderating trend in Q1, with Premium Beauty growing plus 9%, but still ahead of its historical growth of the market
  • Milk Makeup is a cult Gen Z brand with an incredible organic following through an adverse and inclusive community known for its cultural relevance and iconic products

Bear points

  • Net loss was $106 million.
  • Net loss was $3.9 million, an improvement of $9.3 million from a net loss of $13.2 million in quarter one 2023.
Read full transcript analysis ›